EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare

Nina Levhar, Rotem Hadar, Tzipi Braun, Raneen Naamneh, Gilat Efroni, Bella Agranovich, Ifat Abramovich, Adi Talan Asher, Orit Picard, Adi Lahat iD, Doron Yablecovitch iD, Uri Kopylov iD und 5 weitere

United European Gastroenterology Journal · 2025-09 · 13 (7) · 1278-1288

DOI: 10.1002/ueg2.70073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 12.07.2025. Verfasst von Nina Levhar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sheba Medical Center, Tel-Hashomer, Affiliated With the Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Crohn Disease, Feces, Metabolome, Symptom Flare Up. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust, Litwin IBD Pioneers Award, Ministry of Culture and Sport.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolites are key mediators of various physiological functions. However, there is a lack of data linking their levels to future Crohn's Disease (CD) flares.

Objective

We aimed to identify systemic and gut metabolic changes that precede flare and generate metabolite‐based indexes that predict flare using a test cohort, with validation using an independent cohort.

Methods

We analyzed serum and fecal metabolomes in a prospective cohort of patients with quiescent Crohn's Disease monitored until a clinical flare or the end of the study follow‐up.

Results

We identified specific metabolic changes in pre‐flare samples of Crohn's Disease patients and developed prediction models for a subsequent flare using serum and fecal metabolic signatures. Among the fecal metabolites linked to future flares, metabolite classification indicated significantly fewer fatty acids and more carbohydrates in pre‐flare samples of patients that eventually flared. Serum metabolites linked with future flares included reduced levels of two Krebs cycle ketogenic derivatives (3‐hydroxybutyrate and acetoacetate) and higher urate in pre‐flare samples. The predictions based on fecal metabolomics were validated in an independent Crohn's Disease cohort with a similar design. Higher urate levels in the serum metabolomics of the test cohort led us to develop a clinical blood‐based index composed of normalized urate‐to‐creatinine ratio together with CRP [urate/creatinine ratio+log2 (CRP)], which was predictive of flare in the validation cohort 2.

Conclusions

Metabolites linked to future flares can provide insight into mechanisms prompting the transition from quiescent to inflammatory Crohn's Disease states and may help identify those at risk for a clinical flare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFecesMetabolomeSymptom Flare UpHumansMaleFemaleAdultProspective StudiesMetabolomicsMiddle AgedBiomarkersYoung AdultUric Acid

Stichwörter der Autor:innen

Crohn's Diseasefecal metabolomicsflareinflammatory bowel diseasemesaconic acidpredictionquiescentserum metabolomicstrehaloseurate

Substanzen

BiomarkersUric Acid

Autor:innen und Institutionen

  • Sheba Medical Center, Tel-Hashomer, Affiliated With the Tel Aviv University, Tel Aviv, Israel.
  • Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Laura and Isaac Perlmutter Metabolomics Center, Technion-Israel Institute of Technology, Haifa, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Adi Lahat, Doron Yablecovitch, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Yael Haberman

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust
  • Litwin IBD Pioneers Award
  • Ministry of Culture and Sport
  • Horizon 2020 Framework Program
  • Tel Aviv University's Colton Center for Autoimmune Diseases
  • Israel Science Foundation
  • Horizon 2020 Framework Programme

Zitieren

APA

Levhar, N., Hadar, R., Braun, T., Naamneh, R., Efroni, G., Agranovich, B., Abramovich, I., Asher, A. T., Picard, O., Lahat, A., Yablecovitch, D., Kopylov, U., Eliakim, R., Ben-Horin, S., Amir, A., Haberman, Y., & Israeli IBD Research Nucleus (IIRN) (2025). Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare. United European Gastroenterology Journal, 13(7), 1278-1288. https://doi.org/10.1002/ueg2.70073

Vancouver

Levhar N, Hadar R, Braun T, Naamneh R, Efroni G, Agranovich B, et al. Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare. United European Gastroenterology Journal. 2025;13(7):1278-1288. doi:10.1002/ueg2.70073

BibTeX
@article{Levhar2025,
  author = {Levhar, Nina and Hadar, Rotem and Braun, Tzipi and Naamneh, Raneen and Efroni, Gilat and Agranovich, Bella and Abramovich, Ifat and Asher, Adi Talan and Picard, Orit and Lahat, Adi and Yablecovitch, Doron and Kopylov, Uri and Eliakim, Rami and Ben-Horin, Shomron and Amir, Amnon and Haberman, Yael and Israeli IBD Research Nucleus (IIRN), Israeli IBD Research Nucleus (IIRN)},
  title = {Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {7},
  pages = {1278--1288},
  doi = {10.1002/ueg2.70073}
}
Kostenlos starten →